| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $276.2M | +14.2% |
| R&D Expense | $75.7M | +20.6% |
| SG&A Expense | $61.7M | -28.2% |
| Operating Income | -$140.0M | +2.5% |
| Income Tax | -$4.3M | +38.0% |
| Net Income | -$137.4M | +10.3% |
| EPS (Basic) | -$2.56 | +20.7% |
| EPS (Diluted) | -$2.63 | +18.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $116.3M | -39.8% |
| Short-term Investments | $247.2M | -1.8% |
| Accounts Receivable | $48.0M | -1.7% |
| Current Assets | $427.8M | -15.9% |
| Total Assets | $752.3M | -9.6% |
| Current Liabilities | $82.5M | -11.3% |
| Long-term Debt | $226.5M | +25.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.3M | -52.5% |
| Capital Expenditures | $2.2M | -79.3% |
| Investing Cash Flow | -$39.0M | +72.1% |
| Financing Cash Flow | -$2.6M | -101.0% |
| Free Cash Flow | -$37.4M | -11.5% |
| Total Liabilities |
| $327.3M |
| +5.6% |
| Stockholders' Equity | $425.0M | -18.6% |